Trial intelligence / Profile preview

Curcumin vs placebo for auditory neuropathy in chronic kidney disease and diabetes mellitus

IRCT20210620051629N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in auditory neuropathy (ANSD) comparing Curcumin with Placebo (2 arms). Primary endpoint: Primary auditory outcome. Started Aug 2021; status: completed.

02

Drugs

curcumin
03

Conditions

auditory neuropathy (ANSD)

Beyond the preview

Go deeper on IRCT20210620051629N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210620051629N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call